
EOS Imaging
EOS imaging, an ATEC company, is a leader in outcome-improving radiographic imaging and data-informed software solutions.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor investor investor | €0.0 | round |
investor investor investor investor | €0.0 | round | |
N/A | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
* | $79.7m Valuation: $79.7m 3.1x EV/Revenue -11.4x EV/EBITDA | Acquisition | |
Total Funding | 000k |












EUR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | - | (5 %) | (39 %) | 18 % | 62 % | 29 % |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% EBITDA margin | (8 %) | (14 %) | (59 %) | (27 %) | 2 % | 13 % |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% profit margin | (18 %) | (36 %) | (82 %) | (42 %) | (5 %) | 2 % |
EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article, Equity research estimates
Related Content
EOS imaging presents a compelling case in the medical imaging sector, specializing in orthopedic solutions. The company's core technology, which is based on the Nobel Prize-winning work of Georges Charpak, enables low-dose, full-body, 3D imaging of patients in a weight-bearing position. This system provides a comprehensive view of the musculoskeletal system, allowing for precise measurements and analysis of skeletal alignment, a critical factor in orthopedic diagnosis and surgical planning. The company was founded in 2004 by Marie Meynadier, who served as its CEO until 2019. Her background in physics and extensive experience in technology ventures were instrumental in translating a groundbreaking scientific discovery into a commercially viable medical device.
The business operates within the global orthopedic and medical imaging markets, targeting hospitals, orthopedic clinics, and radiology centers as its primary clients. Its revenue model is centered on the sale of its EOS imaging systems, coupled with recurring income from maintenance contracts and software solutions. The product portfolio includes the EOS and EOSedge systems, which are designed to capture high-quality images while significantly reducing the patient's exposure to radiation compared to traditional X-ray and CT scans. This is a particularly strong selling point for pediatric patients and individuals requiring frequent imaging. The company also offers a suite of software tools, such as 3D surgical planning services (EOSapps), which help surgeons prepare for complex procedures like spine, hip, and knee surgeries. In a significant milestone that reshaped its corporate structure, EOS imaging was acquired by Alphatec Holdings, Inc. (ATEC) in 2021, integrating its diagnostic capabilities with ATEC's portfolio of spinal surgery solutions.
This strategic acquisition aims to create a more comprehensive procedural workflow, from initial diagnosis and surgical planning with EOS technology to the execution of spinal fusion surgeries with ATEC's implants and instruments. The integration enhances the value proposition for surgeons by connecting pre-operative imaging and planning directly with intra-operative execution, thereby improving clinical outcomes. The company's journey from a physics-based concept to a key asset in a larger surgical technology corporation illustrates a successful trajectory of innovation and market adaptation in the healthcare industry. Its technology addresses the critical needs for safer imaging and more precise, data-driven surgical interventions in orthopedics.
Keywords: medical imaging, orthopedics, low-dose radiation, 3D imaging, surgical planning, musculoskeletal, spine surgery, medical devices, diagnostic imaging, MedTech
Tech stack
Investments by EOS Imaging
Edit